Page last updated: 2024-10-18

kynurenine and Breast Neoplasms

kynurenine has been researched along with Breast Neoplasms in 34 studies

Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"This study investigated the relationship between the metabolites involved in the tryptophan-kynurenine pathway and psychoneurological symptoms among breast cancer survivors."8.31Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors. ( Danciu, OC; Doorenbos, AZ; Li, H; Liu, T; Lockwood, MB; Schlaeger, JM, 2023)
"The plasmatic kynurenine, tryptophan and kynurenine/tryptophan ratio could differentiate breast cancer patients from healthy controls."7.91Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy. ( Boemer, F; Bours, V; Jerusalem, G; Josse, C; Leduc, S; Onesti, CE, 2019)
"Women with early breast cancer were given a loading dose of L-tryptophan after mastectomy and a comparison made between their excretion of metabolites of the kynurenine pathway and the rate of recurrence of the disease."7.65Tryptophan metabolism and recurrence rates of patients with breast cancer after mastectomy. ( Bell, ED; Bulbrook, RD; Hayward, JL; Tong, D, 1975)
"The kynurenine pathway (KP) has a principal role in the metabolism of tryptophan."5.56Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer. ( Dashti, S; Ghafouri-Fard, S; Kholghi Oskooei, V; Samsami, M; Taheri, M; Taherian-Esfahani, Z, 2020)
"This study investigated the relationship between the metabolites involved in the tryptophan-kynurenine pathway and psychoneurological symptoms among breast cancer survivors."4.31Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors. ( Danciu, OC; Doorenbos, AZ; Li, H; Liu, T; Lockwood, MB; Schlaeger, JM, 2023)
"The plasmatic kynurenine, tryptophan and kynurenine/tryptophan ratio could differentiate breast cancer patients from healthy controls."3.91Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy. ( Boemer, F; Bours, V; Jerusalem, G; Josse, C; Leduc, S; Onesti, CE, 2019)
"Kynurenine, the metabolite generated by IDO, increases in the supernatant of fibroblasts co-cultured with COX-2-overexpressing breast cancer cells."3.80Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression. ( Chen, JY; Hou, MF; Hung, WC; Kuo, CC; Li, CF; Tsai, KK, 2014)
" The current study investigated associations between fatigue, depression and inflammatory cytokine (IFN-γ, IL-6, TNF-α) and CRP concentrations, as well as kynurenine pathway (KP) activation, in 61 breast cancer patients prior to chemotherapy."3.79C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy. ( Boyle, NT; Collier, S; Connor, TJ; Harkin, A; Hevey, D; Hughes, MM; Kennedy, MJ; O'Dwyer, AM; Pertl, MM, 2013)
"Women with early breast cancer were given a loading dose of L-tryptophan after mastectomy and a comparison made between their excretion of metabolites of the kynurenine pathway and the rate of recurrence of the disease."3.65Tryptophan metabolism and recurrence rates of patients with breast cancer after mastectomy. ( Bell, ED; Bulbrook, RD; Hayward, JL; Tong, D, 1975)
"21 adult breast and prostate cancer patients of the TOP study (NCT02883699) were randomized to intervention programs of 12 weeks of (1) endurance standard training or (2) endurance polarized training after a cardiopulmonary exercise test (CPET)."3.01Different endurance exercises modulate NK cell cytotoxic and inhibiting receptors. ( Pal, A; Rosenberger, F; Schlüter, K; Schneider, J; Steindorf, K; Wiskemann, J; Zimmer, P, 2021)
"The kynurenine pathway (KP) has a principal role in the metabolism of tryptophan."1.56Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer. ( Dashti, S; Ghafouri-Fard, S; Kholghi Oskooei, V; Samsami, M; Taheri, M; Taherian-Esfahani, Z, 2020)
"We encountered 32 patients in whom breast cancer recurred 5 or more years after surgery."1.39[Indoleamine 2, 3-dioxygenase activity for breast cancer patients with recurrence 5 or more years after surgery]. ( Amano, S; Enomoto, K; Fujisaki, S; Hara, Y; Maeda, T; Nagashima, S; Sakurai, K; Suzuki, S; Tomita, R, 2013)

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-199013 (38.24)18.7374
1990's0 (0.00)18.2507
2000's1 (2.94)29.6817
2010's13 (38.24)24.3611
2020's7 (20.59)2.80

Authors

AuthorsStudies
Pal, A1
Schneider, J1
Schlüter, K1
Steindorf, K1
Wiskemann, J1
Rosenberger, F1
Zimmer, P1
Li, H2
Lockwood, MB1
Schlaeger, JM1
Liu, T1
Danciu, OC1
Doorenbos, AZ1
Girithar, HN1
Staats Pires, A1
Ahn, SB1
Guillemin, GJ3
Gluch, L3
Heng, B3
Villani, S1
Fallarini, S1
Rezzi, SJ1
Di Martino, RMC1
Aprile, S1
Del Grosso, E1
Panda, S1
Pradhan, N1
Chatterjee, S1
Morla, S1
Saha, A1
Roy, A1
Kumar, S1
Bhattacharyya, A1
Manna, D1
Ghafouri-Fard, S1
Taherian-Esfahani, Z1
Dashti, S1
Kholghi Oskooei, V1
Taheri, M1
Samsami, M1
Karpińska, G1
Dobrowolski, JC1
Yinda, CK1
Rector, A1
Zeller, M1
Conceição-Neto, N1
Heylen, E1
Maes, P1
Ghogomu, SM1
Van Ranst, M1
Matthijnssens, J1
Arthanari, SK1
Vanitha, J1
Ganesh, M1
Venkateshwaran, K1
de Lama Caro-Patón, G1
García-Salido, A1
Iglesias-Bouzas, MI1
Guillén, M1
Cañedo-Villaroya, E1
Martínez-Romera, I1
Serrano-González, A1
Casado-Flores, J1
Gale, P2
Chen, X2
Lucero-Prisno, DE1
Abdullah, AS1
Huang, J1
Laurence, C1
Liang, X1
Ma, Z1
Mao, Z1
Ren, R1
Wu, S1
Wang, N1
Wang, P2
Wang, T1
Yan, H1
Zou, Y1
Olsen, KM1
Gabler, NK1
Rademacher, CJ1
Schwartz, KJ1
Schweer, WP1
Gourley, GG1
Patience, JF1
Rauch, JC1
Stokes, RS1
Shike, DW1
Luebbe, KM1
Stalker, LA1
Klopfenstein, TJ1
Funston, RN1
Unger, PA1
Lighaam, LC1
Vermeulen, E1
Kruithof, S1
Makuch, M1
Culver, EL1
van Bruggen, R1
Remmerswaal, EBM1
Ten Berge, IJM1
Emmens, RW1
Niessen, HWM1
Barnes, E1
Wolbink, GJ1
van Ham, SM1
Rispens, T1
Liang, JX1
Lin, J1
Liu, J2
Wang, X1
Zhang, T1
Li, J1
Wu, Y2
Venier, M1
Salamova, A1
Gonçales, VR1
Lian, J1
Gautam, S1
Tilley, RD1
Gooding, JJ1
Kandel, YR1
Bradley, CA1
Chilvers, MI1
Mathew, FM1
Tenuta, AU1
Smith, DL1
Wise, KA1
Mueller, DS1
Lu, N1
Lu, M1
Liu, P1
Xu, H1
Qiu, X1
Hu, S1
Bai, S1
Wu, J1
Xue, S1
Dai, X1
Dharmage, SC1
Abramson, MJ1
Erbas, B1
Bennett, CM1
Svanes, C1
Hui, J1
Axelrad, C1
Lowe, AJ1
Lodge, CJ1
Hoshi, M1
Osawa, Y1
Nakamoto, K1
Morita, N1
Yamamoto, Y1
Ando, T1
Tashita, C1
Nabeshima, T1
Saito, K1
Gianesello, L1
Del Prete, D1
Ceol, M1
Priante, G1
Calò, LA1
Anglani, F1
Vekaria, HJ1
Hubbard, WB1
Scholpa, NE1
Spry, ML1
Gooch, JL1
Prince, SJ1
Schnellmann, RG1
Sullivan, PG1
Zhang, Q1
Hu, R1
Gu, Z1
Zhang, M1
Zhang, Z1
Peng, Y1
Feng, L1
Li, X3
Zhao, C1
Sarfaraz, K1
Gao, L1
Wang, H1
Wan, C1
Leng, J1
Yang, P1
Gao, X1
Gao, J1
Emam, HE1
Saad, NM1
Abdallah, AEM1
Ahmed, HB1
Palombo, M1
Ianus, A1
Guerreri, M1
Nunes, D1
Alexander, DC1
Shemesh, N1
Zhang, H1
Xiong, Q1
Liu, YS1
Hu, LX1
Shi, ZQ1
Ying, GG1
Chen, R1
Hong, X1
Yan, S1
Zha, J1
Gu, H1
Zhong, Q1
Zeng, Y1
Zhang, S1
Bu, Y1
Farghali, M1
Mayumi, M1
Syo, K1
Satoshi, A1
Seiichi, Y1
Takashima, S1
Ono, H1
Ap, Y1
Yamashiro, T1
Ahmed, MM1
Kotb, S1
Iwasaki, M1
Ihara, I1
Umetsu, K1
Hu, B1
Wang, Y2
Quan, J1
Huang, K1
Gu, X1
Zhu, J1
Yan, Y1
Wu, P1
Yang, L1
Zhao, J1
Koók, L1
Nemestóthy, N1
Bélafi-Bakó, K1
Bakonyi, P1
Luo, X1
Zhang, F1
Li, Q1
Xia, Q1
Li, Z1
Ye, W1
Li, S1
Ge, C1
Zakkula, A1
Pulipati, S1
Dittakavi, S1
Bestha, RM1
Zainuddin, M1
Trivedi, RK1
Mullangi, R1
Lo, GH1
Lin, CW1
Tai, CM1
Perng, DS1
Chen, IL1
Yeh, JH1
Lin, HC1
Rocha, GS1
Silva, MKL1
Cesarino, I1
Hazzaa, SM1
Abdelaziz, SAM1
Abd Eldaim, MA1
Abdel-Daim, MM1
Elgarawany, GE1
Larsson, P1
Ljuslinder, I1
Öhlund, D1
Myte, R1
Löfgren-Burström, A1
Zingmark, C1
Ling, A1
Edin, S1
Palmqvist, R1
Murthi, P1
Rajaraman, G1
Erwich, JJHM1
Dimitriadis, E1
Yoon, HG1
Oh, D1
Ahn, YC1
Noh, JM1
Pyo, H1
Cho, WK1
Song, YM1
Park, M1
Hwang, NY1
Sun, JM1
Kim, HK1
Zo, JI1
Shim, YM1
Persano, A1
Quaranta, F1
Taurino, A1
Siciliano, PA1
Iannacci, J1
Malekbala, MR1
Soltani, S1
Abdul Rashid, S1
Abdullah, LC1
Rashid, U1
Nehdi, IA1
Choong, TSY1
Teo, SH1
Xu, P1
Yan, F1
Zhao, Y1
Sun, S1
Ying, L1
Quinzi, V1
Caruso, S1
Mummolo, S1
Nota, A1
Angelone, AM1
Mattei, A1
Gatto, R1
Marzo, G1
Xin, W1
Severino, J1
Venkert, A1
Yu, H1
Knorr, D1
Yang, JM1
Carlson, L1
Hicks, R1
De Rosa, I1
Beckmann, NA1
Bitsch, RG1
Schonhoff, M1
Siebenrock, KA1
Schwarze, M1
Jaeger, S1
Bilgin, AA1
Lovejoy, DB2
Tan, VX1
Milioli, HH1
Bustamante, S1
Sabaretnam, T1
Moscato, P1
Lim, CK2
Saito, N1
Kanno, Y1
Yamashita, N1
Degawa, M1
Yoshinari, K1
Nemoto, K1
Wei, L1
Zhu, S1
Li, M1
Li, F1
Wei, F1
Ren, X1
Greene, LI1
Bruno, TC1
Christenson, JL1
D'Alessandro, A1
Culp-Hill, R1
Torkko, K1
Borges, VF1
Slansky, JE1
Richer, JK1
Onesti, CE1
Boemer, F1
Josse, C1
Leduc, S1
Bours, V1
Jerusalem, G1
Pertl, MM1
Hevey, D1
Boyle, NT1
Hughes, MM1
Collier, S1
O'Dwyer, AM1
Harkin, A1
Kennedy, MJ1
Connor, TJ1
Sakurai, K5
Fujisaki, S3
Nagashima, S3
Maeda, T3
Tomita, R3
Suzuki, S3
Hara, Y3
Hirano, T2
Enomoto, K5
Amano, S5
Chen, JY1
Li, CF1
Kuo, CC1
Tsai, KK1
Hou, MF1
Hung, WC1
Bekki, K1
Vogel, H1
Li, W1
Ito, T1
Sweeney, C1
Haarmann-Stemmann, T1
Matsumura, F1
Vogel, CF1
Bessede, A1
Matsuo, S1
Tani, M1
Kitajima, A1
Bell, ED2
Teichmann, W1
Knapp, A1
Teichmann, E1
Bulbrook, RD2
Hayward, JL2
Tong, D2
Brown, RR5
Lehrer, S1
Lee, CM1
Song, HK1
Kalnicki, S1
Lipsztein, R1
Dalton, J1
Bloomer, WD1
Rose, DP4
McGinty, F1
Leklem, JE1
Davis, HL1
Leklem, J1
Carlson, IH1
Randall, ZC1
DeGeorge, FV1
Bell, EM1
Mainwaring, WI1

Reviews

3 reviews available for kynurenine and Breast Neoplasms

ArticleYear
Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials.
    British journal of cancer, 2023, Volume: 129, Issue:2

    Topics: Breast Neoplasms; Female; Humans; Kynurenine; Tryptophan

2023
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
Understanding the role of the kynurenine pathway in human breast cancer immunobiology.
    Oncotarget, 2016, Feb-09, Volume: 7, Issue:6

    Topics: Animals; Breast Neoplasms; Female; Humans; Immunity, Cellular; Kynurenine; Signal Transduction

2016

Trials

2 trials available for kynurenine and Breast Neoplasms

ArticleYear
Different endurance exercises modulate NK cell cytotoxic and inhibiting receptors.
    European journal of applied physiology, 2021, Volume: 121, Issue:12

    Topics: Breast Neoplasms; Cells, Cultured; Endurance Training; Exercise Test; Exercise Therapy; Female; Huma

2021
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013

Other Studies

30 other studies available for kynurenine and Breast Neoplasms

ArticleYear
Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors.
    Pain management nursing : official journal of the American Society of Pain Management Nurses, 2023, Volume: 24, Issue:1

    Topics: Breast Neoplasms; Cancer Survivors; Cross-Sectional Studies; Female; Humans; Kynurenine; Tryptophan

2023
Selective inhibition of indoleamine and tryptophan 2,3-dioxygenases: Comparative study on kynurenine pathway in cell lines via LC-MS/MS-based targeted metabolomics.
    Journal of pharmaceutical and biomedical analysis, 2024, Jan-05, Volume: 237

    Topics: Breast Neoplasms; Cell Line; Chromatography, Liquid; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxyg

2024
4,5-Disubstituted 1,2,3-triazoles: Effective Inhibition of Indoleamine 2,3-Dioxygenase 1 Enzyme Regulates T cell Activity and Mitigates Tumor Growth.
    Scientific reports, 2019, 12-05, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents, Immunological; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Line

2019
Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer.
    Experimental and molecular pathology, 2020, Volume: 114

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; Gene Expression Regulat

2020
Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression.
    Breast cancer research : BCR, 2020, 10-27, Volume: 22, Issue:1

    Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cell Line, Tumor; Cohort Stu

2020
The Differential Selectivity of Aryl Hydrocarbon Receptor (AHR) Agonists towards AHR-Dependent Suppression of Mammosphere Formation and Gene Transcription in Human Breast Cancer Cells.
    Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:4

    Topics: Basic Helix-Loop-Helix Transcription Factors; Breast Neoplasms; Cell Survival; Gene Knockout Techniq

2021
High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer.
    Frontiers in immunology, 2018, Volume: 9

    Topics: Adult; Aged; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Endoglin;

2018
A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma.
    Molecular cancer research : MCR, 2019, Volume: 17, Issue:1

    Topics: Breast Neoplasms; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Humans; Kynurenine; Lymphocy

2019
Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy.
    Journal of translational medicine, 2019, 07-23, Volume: 17, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Case-Control Studies; Cell

2019
C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy.
    Brain, behavior, and immunity, 2013, Volume: 34

    Topics: Biomarkers; Breast Neoplasms; C-Reactive Protein; Cytokines; Depression; Fatigue; Female; Humans; In

2013
[Indoleamine 2, 3-dioxygenase activity during neoadjuvant chemotherapy in patients with breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12

    Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Mid

2013
[Indoleamine 2, 3-dioxygenase activity for breast cancer patients with recurrence 5 or more years after surgery].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12

    Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Mid

2013
Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.
    Breast cancer research : BCR, 2014, Jul-25, Volume: 16, Issue:4

    Topics: Adult; Aged; Animals; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Coculture Techni

2014
[Indoleamine 2,3-dioxygenase activity in breast cancer patients with local recurrence or distant metastases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:10

    Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Mid

2014
The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells.
    Pesticide biochemistry and physiology, 2015, Volume: 120

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cyclooxygenase 2; Doxorubicin;

2015
[Indoleamine 2,3-dioxygenase activity during chemotherapy in patients with breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Adult; Age Factors; Breast Neoplasms; Chromatography, High Pressure Liquid; Female; Humans; Indoleam

2009
[Indoleamine 2,3-dioxygenase activity during chemotherapy or hormone therapy in patients with breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Proto

2010
Tryptophan metabolism in Japanese and British women and its relationship to endogenous steroid levels.
    Clinica chimica acta; international journal of clinical chemistry, 1978, Apr-03, Volume: 85, Issue:1

    Topics: 3-Hydroxyanthranilic Acid; Asian People; Breast Neoplasms; Estradiol; Female; Hormones; Humans; Hydr

1978
[Tryptophan metabolism in breast carcinoma].
    Zentralblatt fur Chirurgie, 1976, Volume: 101, Issue:1

    Topics: Aged; Breast Neoplasms; Female; Humans; Kynurenine; Menopause; Middle Aged; Postoperative Complicati

1976
Tryptophan metabolism and recurrence rates of patients with breast cancer after mastectomy.
    Acta vitaminologica et enzymologica, 1975, Volume: 29, Issue:1-6

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Age Factors; Aged; Breast Neoplasms; Female; Huma

1975
Twenty years of tryptophan studies in humans.
    Acta vitaminologica et enzymologica, 1975, Volume: 29, Issue:1-6

    Topics: Breast Neoplasms; Female; Humans; Hydrocortisone; Kynurenine; Liver; Neoplasm Metastasis; Tryptophan

1975
Tryptophan metabolism in women with breast cancer.
    International journal of cancer, 1988, Jul-15, Volume: 42, Issue:1

    Topics: Breast Neoplasms; Female; Humans; Kynurenine; Receptors, Estrogen; Receptors, Progesterone; Tryptoph

1988
Tryptophan metabolism in carcinoma of the breast.
    Lancet (London, England), 1967, Feb-04, Volume: 1, Issue:7484

    Topics: Adult; Aged; Breast Neoplasms; Chromatography, Thin Layer; Estrogens; Female; Humans; Kynurenine; Mi

1967
The influence of adrenocortical hormones and vitamins upon tryptophan metabolism in man.
    Clinical science, 1968, Volume: 35, Issue:1

    Topics: Adrenocorticotropic Hormone; Adult; Benzoates; Breast Neoplasms; Female; Humans; Hydrocortisone; Kyn

1968
Proceedings: Normal and pathological factors which affect tryptophan metabolism in man.
    Zeitschrift fur klinische Chemie und klinische Biochemie, 1972, Volume: 10, Issue:4

    Topics: Breast Neoplasms; Female; Humans; Kynurenine; Pregnancy; Tryptophan; Tryptophan Oxygenase

1972
Tryptophan metabolism in breast cancer. Correlation with urinary steroid excretion.
    Cancer, 1973, Volume: 31, Issue:5

    Topics: 17-Hydroxycorticosteroids; Adult; Aged; Aminohippuric Acids; Androsterone; Breast Neoplasms; Etiocho

1973
Tryptophan metabolism in early and advanced breast cancer and carcinoma of the cervix.
    Clinica chimica acta; international journal of clinical chemistry, 1972, Volume: 40, Issue:1

    Topics: Administration, Oral; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Humans; Kynu

1972
Differences in tryptophan metabolism between breast cancer patients with and without cancer at other sites.
    Cancer, 1970, Volume: 26, Issue:4

    Topics: Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Female; Humans; Kynurenic Acid; Kynurenine; Lung

1970
Relationships between excretion of steroid hormones and tryptophan metabolites in patients with breast cancer.
    The American journal of clinical nutrition, 1971, Volume: 24, Issue:6

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Administration, Oral; Adult; Age Factors; Breast Neoplas

1971
The influence of sex, age and breast cancer on tryptophan metabolism.
    Clinica chimica acta; international journal of clinical chemistry, 1967, Volume: 18, Issue:2

    Topics: Age Factors; Breast Neoplasms; Estrogens; Female; Kynurenine; Menstruation; ortho-Aminobenzoates; Ov

1967